These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 12610802)

  • 1. A randomized double blind, placebo controlled trial of topical Tripterygium wilfordii in rheumatoid arthritis: reanalysis using logistic regression analysis.
    Cibere J; Deng Z; Lin Y; Ou R; He Y; Wang Z; Thorne A; Lehman AJ; Tsang IK; Esdaile JM
    J Rheumatol; 2003 Mar; 30(3):465-7. PubMed ID: 12610802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benefit of an extract of Tripterygium Wilfordii Hook F in patients with rheumatoid arthritis: a double-blind, placebo-controlled study.
    Tao X; Younger J; Fan FZ; Wang B; Lipsky PE
    Arthritis Rheum; 2002 Jul; 46(7):1735-43. PubMed ID: 12124856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic benefit of blocking interleukin-6 activity with an anti-interleukin-6 receptor monoclonal antibody in rheumatoid arthritis: a randomized, double-blind, placebo-controlled, dose-escalation trial.
    Choy EH; Isenberg DA; Garrood T; Farrow S; Ioannou Y; Bird H; Cheung N; Williams B; Hazleman B; Price R; Yoshizaki K; Nishimoto N; Kishimoto T; Panayi GS
    Arthritis Rheum; 2002 Dec; 46(12):3143-50. PubMed ID: 12483717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and efficacy of T-614 in the treatment of patients with active rheumatoid arthritis: a double blind, randomized, placebo-controlled and multicenter trial.
    Lü LJ; Teng JL; Bao CD; Han XH; Sun LY; Xu JH; Li XF; Wu HX
    Chin Med J (Engl); 2008 Apr; 121(7):615-9. PubMed ID: 18466681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of roxithromycin in adult patients with rheumatoid arthritis who had not received disease-modifying antirheumatic drugs: a 3-month, randomized, double-blind, placebo-controlled trial.
    Ogrendik M
    Clin Ther; 2009 Aug; 31(8):1754-64. PubMed ID: 19808134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and tolerability of valdecoxib in treating the signs and symptoms of severe rheumatoid arthritis: a 12-week, multicenter, randomized, double-blind, placebo-controlled study.
    Gibofsky A; Rodrigues J; Fiechtner J; Berger M; Pan S
    Clin Ther; 2007 Jun; 29(6):1071-85. PubMed ID: 17692722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A 48-week, randomized, double-blind, double-observer, placebo-controlled multicenter trial of combination methotrexate and intramuscular gold therapy in rheumatoid arthritis: results of the METGO study.
    Lehman AJ; Esdaile JM; Klinkhoff AV; Grant E; Fitzgerald A; Canvin J;
    Arthritis Rheum; 2005 May; 52(5):1360-70. PubMed ID: 15880810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of hydroxychloroquine sulphate in rheumatoid arthritis: a randomized, double-blind, placebo controlled clinical trial--an Indian experience.
    Das SK; Pareek A; Mathur DS; Wanchu A; Srivastava R; Agarwal GG; Chauhan RS
    Curr Med Res Opin; 2007 Sep; 23(9):2227-34. PubMed ID: 17692155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized, double-blind, multicenter, controlled clinical trial of cyclosporine plus chloroquine vs. cyclosporine plus placebo in early-onset rheumatoid arthritis.
    Miranda JM; Alvarez-Nemegyei J; Saavedra MA; Terán L; Galván-Villegas F; García-Figueroa J; Jara LJ; Barile L;
    Arch Med Res; 2004; 35(1):36-42. PubMed ID: 15036798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rituximab for rheumatoid arthritis refractory to anti-tumor necrosis factor therapy: Results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial evaluating primary efficacy and safety at twenty-four weeks.
    Cohen SB; Emery P; Greenwald MW; Dougados M; Furie RA; Genovese MC; Keystone EC; Loveless JE; Burmester GR; Cravets MW; Hessey EW; Shaw T; Totoritis MC;
    Arthritis Rheum; 2006 Sep; 54(9):2793-806. PubMed ID: 16947627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized double blind trial of an ayurvedic plant derived formulation for treatment of rheumatoid arthritis.
    Chopra A; Lavin P; Patwardhan B; Chitre D
    J Rheumatol; 2000 Jun; 27(6):1365-72. PubMed ID: 10852255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An index of the three core data set patient questionnaire measures distinguishes efficacy of active treatment from that of placebo as effectively as the American College of Rheumatology 20% response criteria (ACR20) or the Disease Activity Score (DAS) in a rheumatoid arthritis clinical trial.
    Pincus T; Strand V; Koch G; Amara I; Crawford B; Wolfe F; Cohen S; Felson D
    Arthritis Rheum; 2003 Mar; 48(3):625-30. PubMed ID: 12632413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of tacrolimus (FK506) in treatment of rheumatoid arthritis: a randomized, double blind, placebo controlled dose-finding study.
    Kondo H; Abe T; Hashimoto H; Uchida S; Irimajiri S; Hara M; Sugawara S
    J Rheumatol; 2004 Feb; 31(2):243-51. PubMed ID: 14760792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Once-weekly administration of 50 mg etanercept in patients with active rheumatoid arthritis: results of a multicenter, randomized, double-blind, placebo-controlled trial.
    Keystone EC; Schiff MH; Kremer JM; Kafka S; Lovy M; DeVries T; Burge DJ
    Arthritis Rheum; 2004 Feb; 50(2):353-63. PubMed ID: 14872476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and efficacy of Ganoderma lucidum (lingzhi) and San Miao San supplementation in patients with rheumatoid arthritis: a double-blind, randomized, placebo-controlled pilot trial.
    Li EK; Tam LS; Wong CK; Li WC; Lam CW; Wachtel-Galor S; Benzie IF; Bao YX; Leung PC; Tomlinson B
    Arthritis Rheum; 2007 Oct; 57(7):1143-50. PubMed ID: 17907228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A phase I study of ethyl acetate extract of the chinese antirheumatic herb Tripterygium wilfordii hook F in rheumatoid arthritis.
    Tao X; Cush JJ; Garret M; Lipsky PE
    J Rheumatol; 2001 Oct; 28(10):2160-7. PubMed ID: 11669150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of valdecoxib and naproxen in the treatment of rheumatoid arthritis symptoms.
    Williams GW; Kivitz AJ; Brown MT; Verburg KM
    Clin Ther; 2006 Feb; 28(2):204-21. PubMed ID: 16678642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of clarithromycin in patients with active rheumatoid arthritis.
    Ogrendik M
    Curr Med Res Opin; 2007 Mar; 23(3):515-22. PubMed ID: 17355733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pilot clinical trial of intravenous doxycycline versus placebo for rheumatoid arthritis.
    Pillemer S; Gulko P; Ligier S; Yarboro C; Gourley M; Goldbach-Mansky R; Siegel R; Hirsch R; Pucino F; Tilley B; Wilder RL
    J Rheumatol; 2003 Jan; 30(1):41-3. PubMed ID: 12508388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inpatient treatment of rheumatoid arthritis with synacthen depot: a double blind placebo controlled trial with 6 month followup.
    Taylor WJ; Rajapakse CN; Harris KA; Harrison AA; Corkill MM
    J Rheumatol; 1999 Dec; 26(12):2544-50. PubMed ID: 10606361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.